| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |